These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27287177)

  • 1. Overview of biopolymers as carriers of antiphlogistic agents for treatment of diverse ocular inflammations.
    Sharma AK; Arya A; Sahoo PK; Majumdar DK
    Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():779-791. PubMed ID: 27287177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent perspectives for corticosteroids based ophthalmic therapeutics.
    Suresh PK; Sah AK
    Recent Pat Drug Deliv Formul; 2014; 8(3):206-23. PubMed ID: 25020063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological macromolecules for ophthalmic drug delivery to treat ocular diseases.
    Krishnaswami V; Kandasamy R; Alagarsamy S; Palanisamy R; Natesan S
    Int J Biol Macromol; 2018 Apr; 110():7-16. PubMed ID: 29378276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-based carriers for ophthalmic drug delivery.
    Imperiale JC; Acosta GB; Sosnik A
    J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.
    Souto EB; Doktorovova S; Gonzalez-Mira E; Egea MA; Garcia ML
    Curr Eye Res; 2010 Jul; 35(7):537-52. PubMed ID: 20597640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Release from Porous Matrixes based on Natural Polymers.
    Kaczmarek B; Sionkowska A
    Curr Pharm Biotechnol; 2017; 18(9):721-729. PubMed ID: 29110601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymers and their engineered analogues for ocular drug delivery: Enhancing therapeutic precision.
    Biswas A; Kumar S; Choudhury AD; Bisen AC; Sanap SN; Agrawal S; Mishra A; Verma SK; Kumar M; Bhatta RS
    Biopolymers; 2024 Jul; 115(4):e23578. PubMed ID: 38577865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular drug delivery system: a reference to natural polymers.
    Pahuja P; Arora S; Pawar P
    Expert Opin Drug Deliv; 2012 Jul; 9(7):837-61. PubMed ID: 22703523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan nanoparticles for drug delivery to the eye.
    Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ
    Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteins.
    Radhakrishnan K; Sonali N; Moreno M; Nirmal J; Fernandez AA; Venkatraman S; Agrawal R
    Drug Discov Today; 2017 Feb; 22(2):416-423. PubMed ID: 27818255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability.
    Sithole MN; Choonara YE; du Toit LC; Kumar P; Pillay V
    Pharm Dev Technol; 2017 Mar; 22(2):283-295. PubMed ID: 27470222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery.
    Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
    Eur J Pharm Biopharm; 2017 Jan; 110():70-75. PubMed ID: 27789358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectoine in the Treatment of Irritations and Inflammations of the Eye Surface.
    Bilstein A; Heinrich A; Rybachuk A; Mösges R
    Biomed Res Int; 2021; 2021():8885032. PubMed ID: 33628826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of topical diclofenac sodium, a non-steroidal anti-inflammatory drug, on various ocular inflammatory models in animals].
    Agata M; Abe T; Kon M; Tanaka M; Kimura T; Nakajima A
    Nippon Ganka Gakkai Zasshi; 1983; 87(1):19-28. PubMed ID: 6846097
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
    Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
    J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
    Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
    AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric delivery systems for dexamethasone.
    Urbańska J; Karewicz A; Nowakowska M
    Life Sci; 2014 Feb; 96(1-2):1-6. PubMed ID: 24373835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E₂-induced ocular inflammation.
    Mathurm M; Gilhotra RM
    Drug Deliv; 2011 Jan; 18(1):54-64. PubMed ID: 20718601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.